Abstract LB220: The anticalin-antibody bispecific PRS-352/S095025 strongly stimulates human CD4+ T cells in a PD-L1-dependent manner

Lucia Pattarini(Servier (France)), Shane A. Olwill(Pieris Pharmaceuticals (United States)), Matthieu Rivière(Servier (France)), Janet K. Peper-Gabriel, Aizea Kastresana Morales(Pieris Pharmaceuticals (United States)), Didier Demarles(Servier (France)), Marina Pavlidou(Pieris Pharmaceuticals (United States)), Véronique Blanc(Imperial College London), Alix Scholer‐Dahirel(Servier (France))
Cancer Research
June 15, 2022
Cited by 2


Related Papers